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Abstract 
Background: Insecticide-treated net (ITN) durability, measured through physical integrity and bioefficacy, must 
be accurately assessed in order to plan the timely replacement of worn out nets and guide procurement of longer-
lasting, cost-effective nets. World Health Organization (WHO) guidance advises that new intervention class ITNs be 
assessed 3 years after distribution, in experimental huts. In order to obtain information on whole-net efficacy cost-
effectively and with adequate replication, a new bioassay, the Ifakara Ambient Chamber Test (I-ACT), a semi-field 
whole net assay baited with human host, was compared to established WHO durability testing methods.
Methods: Two experiments were conducted using pyrethroid-susceptible female adult Anopheles gambiae sensu 
stricto comparing bioefficacy of  Olyset®,  PermaNet® 2.0 and  NetProtect® evaluated by I-ACT and WHO cone and tun-
nel tests. In total, 432 nets (144/brand) were evaluated using I-ACT and cone test.  Olyset® nets (132/144) that did not 
meet the WHO cone test threshold criteria (≥ 80% mortality or ≥ 95% knockdown) were evaluated using tunnel tests 
with threshold criteria of ≥ 80% mortality or ≥ 90% feeding inhibition for WHO tunnel and I-ACT. Pass rate of nets 
tested by WHO combined standard WHO bioassays (cone/tunnel tests) was compared to pass in I-ACT only by net 
brand and time after distribution.
Results: Overall, more nets passed WHO threshold criteria when tested with I-ACT than with standard WHO bioas-
says 92% vs 69%, (OR: 4.1, 95% CI 3.5–4.7, p < 0.0001). The proportion of  Olyset® nets that passed differed if WHO 2005 
or WHO 2013 LN testing guidelines were followed: 77% vs 71%, respectively. Based on I-ACT results,  PermaNet® 2.0 
and  NetProtect® demonstrated superior mortality and non-inferior feeding inhibition to  Olyset® over 3 years of field 
use in Tanzania.
Conclusion: Ifakara Ambient Chamber Test may have use for durability studies and non-inferiority testing of new ITN 
products. It measures composite bioefficacy and physical integrity with both mortality and feeding inhibition end-
points, using fewer mosquitoes than standard WHO bioassays (cone and tunnel tests). The I-ACT is a high-throughput 
assay to evaluate ITN products that work through either contact toxicity or feeding inhibition. I-ACT allows mosqui-
toes to interact with a host sleeping underneath a net as encountered in the field, without risk to human participants.
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Background
National malaria control programmes (NMCPs) must 
ensure that all people living in malaria transmission areas 
are protected through the provision, nightly use and 
timely replacement of high quality long-lasting insecti-
cidal nets (ITNs) and where appropriate, the additional 
application of indoor residual spraying (IRS) [1]. While it 
is assumed that all ITNs that have World Health Organi-
zation (WHO) prequalification listing last for 3  years, 
several ITN products are available that may vary in price 
as well as performance under local conditions [1–7]. 
Because ITNs are the primary means of malaria con-
trol, their durability, measured through physical integrity 
and bioefficacy against anopheline mosquitoes, needs to 
be accurately assessed in order to inform NMCPs of the 
most cost effective products and the correct interval for 
net replenishment campaigns [8].
Any ITN product is expected to retain its insecticidal 
activity (bioefficacy) for a minimum number of 20 stand-
ard washes or 3  years of use under field conditions as 
defined by the WHO [9]. However, the durability (years 
of functional life) of both existing and new net products 
under development is a crucial consideration. Despite 
mass distribution of ITNs, currently fewer than 50% of 
people living in malaria endemic areas are covered by 
one of the core malaria interventions: either ITNs or IRS 
[10]. Maximizing ITN access through the provision of the 
most long-lasting, and cost-effective products remains 
a critical concern, particularly as a number of coun-
tries have shown an increase in malaria in the past year 
(2016/2017) as investments in malaria control have pla-
teaued [10].
For products within new intervention classes e.g. 
dual active ITNs, an Evidence Review Group (ERG) 
report to the WHO Malaria Policy Advisory Commit-
tee (MPAC) recommended specific guidance on the 
assessment of non-inferiority of products within a class 
[11]. A non-inferiority trial of an intervention aims to 
demonstrate that the test product is not worse than 
the comparator/reference by more than a pre-specified 
margin [12], known as the non-inferiority margin. For 
ITNs this margin relates to mortality or feeding inhibi-
tion. In recognition of the importance of ITN durability, 
the WHO recommended that once sufficient test and 
active comparator ITNs from large-scale field trials have 
been collected over 3  years of field use, a second set of 
two non-inferiority trials should be conducted to ensure 
that the test product continues to be non-inferior to the 
comparator/reference product for up to 3 years on both 
mosquito mortality and blood-feeding inhibition end-
points [13]. While this guidance recommended that non-
inferiority trials should be conducted in experimental 
huts it was acknowledged that alternative methodology 
for non-inferiority testing including the ambient cham-
ber test or the tunnel test should be explored.
The standard means of ITN bioefficacy evaluation is 
through cone bioassays, WHO tunnel tests and experi-
mental hut evaluations [14]. The cone test is a contact 
assay where mosquitoes are held in proximity to the ITN 
and mosquito knockdown (KD60) and 24-h mortality are 
recorded after 60 min and 24 h, respectively. The tunnel 
test uses a live animal as a bait (rabbit or guinea pig), so 
mosquitoes are able to exercise host-seeking behaviour, 
and ITN efficacy is assessed by measuring mosquito 
mortality and blood feeding inhibition [15–17]. Experi-
mental huts are small scale field (phase II) testing assays 
used to evaluate ITNs that meet laboratory (phase I) 
testing criteria [8, 18]. Huts are built in areas with high 
densities of target mosquito species and are designed to 
resemble small local housing but have features to retain 
mosquitoes that enter huts such as window traps and baf-
fles [19]. Volunteers sleep underneath the ITNs and wild 
mosquitoes attempt to feed and interact with the ITNs in 
the same way as they would in local homes. Both mor-
tality and feeding inhibition are key outcome parameters, 
which translate to personal and community protection 
from malaria [20].
However, all assays have some limitations, which need 
to be considered when assessing bioefficacy of ITNs. 
WHO cone tests may underestimate the induced mortal-
ity of irritant insecticides, as mosquitoes do not settle on 
treated nets [21]. Indeed, comparatively higher mortality 
is often measured in experimental hut studies of ITNs 
where mosquitoes make repeated contacts with treated 
nets as they try to feed on human volunteers sleeping 
under nets. In the WHO tunnel test, the live host used as 
bait is not the preferred host for the strongly anthropo-
philic Afro-tropical vector Anopheles gambiae sensu 
stricto (s.s.) [22] and may overestimate feeding inhibi-
tion. Alternatively, mosquitoes must be reared by feeding 
them on small mammals to select them for a preference 
to these non-preferred hosts, which is both expensive 
and of animal welfare concern. Experimental hut bioas-
says are the gold standard for ITN and IRS evaluation, 
but wild mosquito populations are often seasonal and 
have high temporal heterogeneity requiring substantial 
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replication to ensure adequate power to detect true effect 
differences between products [23].
Therefore, presented here is the first evaluation of a 
new standardized semi-field assay: the Ifakara Ambi-
ent Chamber Test (I-ACT) assay. The assay was used to 
evaluate the bioefficacy of whole ITNs that were returned 
from the field in a longitudinal durability study. This 
study measured the bioefficacy of used (field-aged) ITNs 
using the I-ACT assay and standard WHO durability 
testing bioassays (cone and tunnel tests). The proportion 
of nets passing WHO criteria by standard methods and 
I-ACT was compared. The aim was to demonstrate the 
utility of this new assay for measuring bioefficacy of dif-
ferent ITN products and to explore its applicability for 
non-inferiority testing of new ITN products [11]. Further 
work comparing the I-ACT and experimental hut evalua-
tions of ITNs will be reported separately.
Methods
Study design
Bioefficacy tests were conducted as part of a 3-year pro-
spective project (the ABCDR-Attrition, Bioefficacy, 
Chemical residual, Damage and Resistance project) to 
assess of the useful life of three brands of ITNs in Tan-
zania [24]. The main design characteristics of each bioas-
say performed in this study are presented in Table 1. The 
study involved two experiments. In the first experiment, 
ITNs efficacy, measured by cone bioassay and I-ACT 
were compared. In the second experiment, ITNs bioeffi-
cacy measured by WHO tunnel test and the I-ACT was 
compared. The overall pass/fail rate for each net brand 
by year were examined following the criteria outlined 
in both 2005 and the 2013 World Health Organization 
guidelines for evaluation of long lasting nets [14, 25]. The 
pass rate of each product by standard WHO methods 
and I-ACT was compared.
Mosquito rearing
Mosquitoes used during testing were laboratory-reared 
fully pyrethroid susceptible 3–8 days old female adult An. 
gambiae s.s. (Ifakara strain, Njage 1996) reared following 
standard methods [26].
Mosquito nets
All mosquito nets used in this study came from a 3-years 
prospective longitudinal follow-up study between 2013 
and 2016 (ABCDR Project) conducted in eight districts of 
Tanzania. Net samples were randomly selected using net 
codes from master list from the three surveys conducted 
between October and December 2014 (year 1), October–
December 2015 (year 2) and October–December 2016 
(year 3). The detailed description of the ABCDR Project 
Table 1 Design characteristics of the WHO cone test, WHO tunnel test and I-ACT 
Particular WHO cone test WHO tunnel test Ifakara Ambient Chamber test 
(I-ACT)
Diagram
Endpoints measured Knock down (KD 60), 24-h mortality 12-h mortality, 24-h mortality, feed-
ing inhibition
12-h mortality, 24-h mortality, feed-
ing inhibition
Infrastructure required Temperature controlled room, 
boards, aspirators, cones, insect 
rearing facilities
Temperature controlled room, 
tunnel, aspirators, insect rearing 
facilities, animal rearing facilities
Ambient or temperature controlled 
chambers, temperature con-
trolled holding room, aspirators, 
insect rearing facilities
Bait used No Rabbit, guinea pig Human
Mosquitoes per net 80 100 30
Exposure time 3 min 12–15 h 12 h
Holding time 24 h None 24 h
Time to conduct including prepara-
tion
25 h 16 h 26 h
Surface area exposed to mosquitoes 78 cm2 625 cm2 145,200 cm2
Useful for durability monitoring Measures presence of insecticide Measures mortality and feeding 
inhibition on a small section of net
Measures the functional efficacy of 
nets under user conditions
Useful for non-inferiority testing Not suitable for some ITN products Works for all ITNs Works for all ITNs
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has been reported previously [24]. Three net brands were 
used for this study: (1)  Olyset® net (permethrin incor-
porated into polyethylene fibres @ 1000  mg/m2), (2) 
 PermaNet® 2.0 net (deltamethrin coated on polyester 
fibres @ 55  mg/m2) and (3)  Netprotect® net (deltame-
thrin incorporated into polyethylene fibres @ 63 mg/m2). 
All nets were rectangular, white, double sized (190  cm 
length × 180  cm width × 150  cm height) and recom-
mended by WHO [27]. All nets were used in the I-ACT 
as found i.e. with damage due to wear and tear. In the first 
experiment, to compare between cone test and I-ACT, a 
total of 432 nets (144 per net brand) were evaluated and 
results compared. In the second experiment to compare 
between tunnel test and I-ACT, nets those failed to meet 
cone test threshold criteria in the first experiment were 
assessed using WHO tunnel test (132 nets) and their 
results were compared with those from I-ACT.
Ifakara Ambient Chamber Test (I-ACT)
This is a 50 m long, 3 m wide and 2.1 m high steel tube 
frame construction (Fig.  1a) covered by durable UV 
resistant polyurethane coated netting with an overlaid 
polyurethane sheet to minimize wind so that bioassays 
are conducted in still air (as would occur in a house). 
The structure is constructed upon a concrete base sur-
rounded by a water channel to prevent entry by ants 
and spiders that eat mosquitoes during the conduct of 
experiments. The tunnel sits beneath a simple beamed 
wooden frame supporting a corrugated steel roof to 
allow work to continue in all weather conditions. The 
netted tunnel is divided into ten individual test cham-
bers with interconnecting doors that are sealed by 
means of zips and Velcro to prevent mosquitoes mov-
ing from one test chamber to another. Each compart-
ment contains a white netted chamber 5  m long, 2  m 
wide, and 2 m high that seals with a zip, in which the 
ITN is hung from a frame with a human volunteer 
sleeping underneath (Fig. 1b). At each end of the tunnel 
is an additional double door module to ensure no loss 
of laboratory-reared mosquitoes into the wild. Mosqui-
toes are released from the holding cages within each 
netted chamber by means of raising a netted cage from 
its removable wooden base. This is achieved by the 
technician in  situ underneath his net pulling a nylon 
line attached to the mosquito release cage to elevate it 
(Fig.  1c). After the allotted experimental time period 
all mosquitoes within each of the compartments are 
recovered by mouth aspiration (for mosquitoes inside 
the net) and by a battery powered Prokopack aspi-
rator (for mosquitoes outside the net but inside the 
compartment). This allows whole ITNs to be tested in 
a controlled ambient chamber test with a human host 
Fig. 1 The I-ACT. Ifakara Tunnel situated at Bagamoyo branch of IHI (a). Net covered tunnel divided into 10 individual compartments each 
containing netted cage 2 × 2 × 5 m (b). The volunteer releases mosquitoes by opening the lid of the holding boxes while beneath the tested net 
(c). A human volunteer sleeps underneath the ITN (d)
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sleeping beneath (Fig.  1d) to measure the protective 
efficacy (both personal protection measured by feed-
ing inhibition and community protection measured by 
mosquito mortality) under user conditions. The design 
of the chambers allows 100% recovery of released mos-
quitoes that improves precision of the data, and experi-
ments can be conducted year-round.
Each of the ten testing chambers was randomly 
assigned one whole net (with wear and tear as found after 
use for 1, 2 or 3 years) from one of the three net brands 
using a random number generator. Two chambers were 
used each night as negative control with untreated SAFI 
Net (A to Z, Tanzania) holed with six holes 4 × 4  cm 
(Additional file  1) i.e. two holes on each large side and 
one hole on each small side (hole surface area of 96 cm2) 
according to WHO guidance [9]. One adult volunteer 
per chamber slept underneath the nets from 21:00 to 
06:30 h and collected mosquitoes in the mornings. Each 
volunteer was fixed to the same chamber for the dura-
tion of the experiment. On each night of experiment, 
each volunteer hung the tested net on the bednet frame 
and tucked it underneath the mattress (between 28 and 
35 cm of each net was tucked). At 21:00 h, each volunteer 
released 30 mosquitoes within the chamber but outside 
of the ITN by opening the mosquito release cage while 
remaining beneath their test net. The following morn-
ing, at 06:30 h, mosquitoes inside the net were collected 
first using a mouth aspirator and mosquitoes outside the 
net but within the chamber (floor and walls) were col-
lected using a 6  V battery driven mechanical aspirator 
(Prokopack). A study supervisor checked the start and 
finish of the experiment and intermittently spot checked 
that the volunteers were in position overnight to ensure 
good conduct of the experiment. All collected mosqui-
toes were placed in paper cups and scored as dead-fed, 
alive-fed, dead-unfed, alive-unfed after which mosquitoes 
were held for 24 h in the laboratory with access to 10% 
sugar solution at 27 °C ± 2 and 80% ± 10 relative humid-
ity and scored again. After every experimental night, all 
tested nets were taken out and chambers were aired and 
bed sheets were washed daily to prevent any carry-over 
insecticide residue. Each net sample was tested on two 
consecutive nights (fixed to a chamber and volunteer) to 
improve the precision of the estimation of performance 
of each net. Outcome measures were 24  h mortality 
and blood feeding inhibition. Nets that induced ≥ 90% 
blood-feeding inhibition and/or ≥ 80% mortality were 
regarded as meeting WHO efficacy criteria. Data were 
discarded and test repeated if control mortality exceeded 
10% or control blood-feeding success was less than 50%. 
A Standard Operating Procedure for conducting Ifakara 
Ambient Chamber Test is provided as an Additional 
file 2.
Cone tests
Cone tests were conducted following WHO guidelines 
[8] to determine the bioefficacy of insecticides on sam-
pled netting pieces. For each of the sampled whole nets, 
after completion of the I-ACT, four 30 cm × 30 cm sub-
samples were cut from positions 2, 3, 4 and 5 from each 
net sample (Additional file  3). Cone bioassays were 
held at a 60° vertical angle on the netting sub-samples 
[28]. Anopheles gambiae s.s., aged 3–5  days old, were 
exposed for 3 min after which they were held for 24 h 
with access to 10% sugar solution at 27  °C ± 2 and 
80% ± 10 relative humidity. The numbers of mosquitoes 
knocked down after 60  min (KD60) and dead at 24  h 
post-exposure were recorded. A sub-sampled net that 
caused ≥ 95% KD60 and/or ≥ 80% 24 h mortality in the 
cone test was regarded as meeting WHO efficacy cri-
teria. Tests, where control mortality at 24  h exceeded 
10%, were discarded and repeated.
WHO tunnel test
WHO tunnel tests were conducted following WHO 
guidelines [8] to assess the efficacy of netting sub-sam-
ples that failed to meet the WHO threshold criteria for 
cone test (95% KD60 and/or 80% 24  h mortality). The 
surface area of the sample netting accessible to mos-
quitoes was approximately 625  cm2 (25 × 25  cm) with 
nine holes cut in the net, each 1 cm in diameter: one at 
the centre of the square and the other eight holes were 
equidistant and located 5 cm from the border. The sam-
pled net piece was inserted on a cardboard frame and 
positioned across the tunnel, one-third of the length of 
the tunnel. A total of 100 sugar-starved An. gambiae 
s.s. aged 5–8  days were released in the long section 
of the glass tunnel at 18:00  h. A rabbit was used as a 
bait and positioned on the other side of the net so that 
mosquitoes must pass through the holed net to access 
the bait and feed. The following morning, between 
06:00 and 09:00  h, mosquitoes were removed (sepa-
rately from each section of the tunnel) using a mouth 
aspirator, counted, scored as alive or dead, blood fed or 
unfed after which they were held for 24  h with access 
to 10% sugar solution at 27  °C ± 2 and 80% ± 10 rela-
tive humidity. The main outcome measures were 12  h 
mortality measured in the morning after the experi-
ment and blood feeding inhibition [14]. The 24 h mor-
tality was also recorded as a secondary outcome [25]. 
Nets that caused ≥ 90% blood-feeding inhibition and/
or ≥ 80% mortality was regarded as meeting WHO effi-
cacy criteria [25]. Tests were discarded if control mor-
tality at 24  h exceeded 10% or control blood-feeding 
success was less than 50%.
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Data management and analysis
A sample size calculation for generalized linear mixed 
effects models (GLMMs) through simulation [12] in R 
statistical software 3.02 http://www.r-proje ct.org [13] 
was performed for the semi-field experiments to detect 
a difference between the nets of 5% mortality (half the 
smallest anticipated effect size). Simulations were per-
formed using an estimated mosquito mortality of 70% 
with the  Olyset® and 80% for the  PermaNet® 2.0 and 
 NetProtect®. With 44 replicates tested on two occasions 
with an inter-observational variance of 0 for the cham-
ber (controlled environment) and 0.1 for individual and 
0.1 for the night of observation based on the variance of 
the random effects observed in a pilot study. Power was 
estimated at > 90% with a density of 30 mosquitoes per 
chamber per night using 1000 simulations.
Data were collected on standardized data collection 
forms and double entered into Microsoft Excel. Data 
were cleaned and analysed following a predefined analy-
sis plan using STATA 14.1 (Stata Corp., College Station 
TX, USA) with significance level of ≤ 0.05 for reject-
ing the null hypothesis. Descriptive statistics were used 
to present the comparison of proportion of nets passing 
WHO threshold criteria as measured by each method. 
Generalized linear mixed models (GLMM) with a bino-
mial error distribution and logit link function were used 
to analyse the main outcome measures from cone, tun-
nel and I-ACT (mortality and blood feeding) as well as 
the proportion of nets passing WHO criteria in order to 
detect differences between the two evaluation methods. 
Net brand, age of net and bioassay method were fitted as 
fixed effects while date was fitted as a random effect to 
account for repeated testing of individual nets. Several 
GLMMs were run for each comparison (with interac-
tions) and the final model selected was that with the low-
est Akaike’s Information Criterion (AIC). Residuals were 
plotted using histogram, qnorm plots and comparison 
with fitted values to ensure appropriateness of the model 
selection and testing if the residuals are normally distrib-
uted. Odds ratio (OR) and 95% confidence interval were 
calculated for the differences between methods in each 
comparison.
In addition, non-inferiority between net products 
 (PermaNet® 2.0,  Netprotect® with  Olyset® as reference/
comparator) measured by I-ACT was analysed using 
a paired t-test with a 90% confidence interval of the 
observed effect difference in the mortality and blood-
feeding inhibition rates to measure non-inferiority at a 
margin of 10% and data were presented for comparison 
using a Forest Plot [29].
Results
Comparison between cone test and I-ACT 
The data presented in Table  2 show that a smaller per-
centage of nets passed WHO threshold criteria using 
cone test 62% (268/432) than passed using by I-ACT 97% 
(417/432) irrespective of brand and net age (cone test cri-
teria ≥ 80% 24-h mortality and/or ≥ 95% KD60; I-ACT 
criteria ≥ 80% 24-h mortality).
Using cone bioassays, 8% (12/145) of  Olyset® nets, 
88% (126/144) of  PermaNet® 2.0 nets and 91% (130/143) 
of  NetProtect® nets passed the cone test. When tested 
by the I-ACT, 94% (137/145)  Olyset®, 98% (141/144) 
 PermaNet® 2.0 and 97% (139/143)  NetProtect® passed 
(Table  2). Table  3 shows that, overall, I-ACT measured 
higher 24 h mosquito mortality than cone test regardless 
of net brand (OR: 7.9, 95% CI 7.4–8.4, p < 0.0001). Disag-
gregated by brand the same trend was evident and I-ACT 
measured higher mortality than cone test:  Olyset® nets 
(OR: 17.8, 95% CI 16.3–19.5%; p < 0.0001),  PermaNet® 2.0 
(OR: 2.1, 95% CI 1.8–2.3%; p < 0.0001) and  Netprotect® 
(OR: 3.6, 95% CI 3.2–4.1, p < 0.0001).
Comparison between WHO tunnel test and I‑ACT 
A total of 164 nets (132  Olyset®, 19  PermaNet® net and 
13  Netprotect®) did not meet the WHO threshold cri-
teria for cone test and therefore went for WHO tunnel 
tests. Only bio-efficacy results of  Olyset® sampled nets 
were used for comparison with I-ACT to ensure an ade-
quately replicated and paired comparison, because the 
Table 2 Percentage and number of nets (by brand and age) meeting the standard WHO 2013 threshold criteria by I-ACT 
and cone tests
WHO 2013 pass/fail criteria: cone test: ≥ 95% KD60 and/or ≥ 80% 24 h mortality and I-ACT: ≥ 80% 24 h mortality and/or ≥ 90% blood feeding inhibition
Age of net Year 1 Year 2 Year 3 Overall
Cone test I-ACT Cone test I-ACT Cone test I-ACT Cone test I-ACT 
Olyset Net 4% (2/49) 100% (49/49) 8% (4/48) 96% (46/48) 13% (6/48) 86% (42/48) 8% (12/145) 94% (137/145)
PermaNet 2.0 98% (47/48) 100% (48/48) 92% (44/48) 98% (47/48) 73% (35/48) 96% (46/48) 88% (126/144) 98% (141/144)
Netprotect 100% (47/47) 100% (47/47) 100% (48/48) 100% (48/48) 73% (35/48) 92% (44/48) 91% (130/143) 97% (139/143)
Overall 67% (96/144) 100% (144/144) 67% (96/144) 98% (141/144) 53% (76/144) 92% (132/144) 62% (268/432) 97% (417/432)
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majority of  PermaNet® 2.0 and  Netprotect® sub-sampled 
nets passed the cone test.
The overall proportion of Olyset nets meeting WHO 
thresholds in tunnel test using methods outlined in 
WHO 2013 guidance (mortality recorded the morning 
after bioassay) and I-ACT is shown in Table  4. In addi-
tion, further analysis based on WHO 2005 guidance 
(mortality recorded after 24  h holding) was also per-
formed and included in the results for comparison. Over-
all, results from Table  4 shows, regardless of the WHO 
ITN testing guideline used, more  Olyset® nets passed 
when measured in I-ACT than in tunnel test (using 24-h 
mortality OR: 5.7, 95% CI 2.5–, p < 0.0001).
Using either 12  h mortality or 24-h mortality, I-ACT 
recorded higher mortality than the tunnel test (Table 5). 
At 12  h, 64.1%, (95% CI 60.1–68.3%) vs 49.5% (95% CI 
44.5–54.6%) (OR 1.7 (1.6–1.8), p < 0.0001) at 12  h and 
71.2% (95% CI 67.7–74.9%) vs 64.4% (95% CI 59.8–69.4%) 
(OR 1.3 (1.2–1.4), p < 0.0001) at 24  h. For  Olyset® nets 
mortality was significantly higher measured after a 24-h 
holding period compared to the morning of collection 
in WHO tunnel test but not I-ACT (Fig.  2). Feeding 
Table 3 Measurements of percentage 24 h mortality compared between WHO cone test and I-ACT by net brand and age
24 h geometric mean  % mortality (95% confidence interval) Odds ratio 95% confidence 
interval
p-value
Year 1 Year 2 Year 3 Overall
Olyset®
 Cone test 19.4 (17.9–20.9) 7.2 (6.2–8.2) 34.1 (32.1–36.2) 20.2 (19.2–21.2) 1
 I-ACT 87.2 (84.1–90.3) 68.9 (64.5–73.4) 69.8 (65.4–74.3) 75.1 (72.5–77.6) 17.8 16.3–19.5 < 0.0001
PermaNet® 2.0
 Cone test 93.5 (92.4–94.7) 85.3 (83.3–87.2) 83.2 (81.4–85.1) 87.4 (86.4–88.3) 1
 I-ACT 98.4 (97.7–99.1) 91.5 (88.8–94.2) 87.8 (84.2–91.5) 92.5 (90.9–94.1) 2.1 1.8–2.3 < 0.0001
Netprotect®
 Cone test 93.1 (92.1–94.2) 81.1 (78.9–83.3) 82.2 (80.1–83.7) 85.4 (84.4–86.4) 1
 I-ACT 99.1 (98.6–99.6) 96 (94.4–97.6) 89.1 (85.9–92.1) 94.6 (93.4–95.9) 3.6 3.2–4.1 < 0.0001
Overall
 Cone test 68.2 (66.6–69.8) 58 (56.2–59.8) 66.5 (65.1–67.9) 64.2 (63.3–65.2) 1
 I-ACT 94.9 (93.7–96.2) 85.5 (83.2–87.7) 82.2 (79.8–84.5) 87.4 (86.2–88.6) 7.9 7.4–8.4 < 0.0001
Table 4 Overall percentage of sampled  Olyset® nets that met the standard WHO threshold criteria as measured by I-ACT 
and tunnel test following both WHOPES 2013 and 2005 guidelines
Odds ratios are calculated on 2005 criteria
WHOPES 2005 pass/fail criteria: tunnel test: feeding inhibition and/or ≥ 80% 24 h mortality
WHOPES 2013 pass/fail criteria: tunnel test: ≥ 90% feeding inhibition and/or ≥ 80% 12 h mortality
I-ACT: ≥ 80% 24 h mortality and/or ≥ 90% blood feeding inhibition
No. of nets % pass WHO 2013 criteria 
(n = number passed)
% pass WHO 2005 criteria 
(n = number passed)
Odds ratio 95% confidence 
interval
p-value
Year 1
 Tunnel test 47 60% (n = 29) 72% (n = 33) 1
 I-ACT 47 100% (n = 47) 100% (n = 47) 19.9 2.5–159.1 0.005
Year 2
 Tunnel test 44 75% (n = 33) 77% (n = 34) 1
 I-ACT 44 95% (n = 42) 95% (n = 41) 6.1 1.2–29.3 0.025
Year 3
 Tunnel test 41 66% (n = 27) 71% (n = 29) 1
 I-ACT 41 78% (n = 32) 76% (n = 31) 2.1 0.7–6.2 0.187
Overall
 Tunnel test 132 67% (n = 91) 72% (n = 96) 1
 I-ACT 132 92% (n = 121) 91% (n = 120) 5.7 2.5–12.9 < 0.0001
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inhibition (Fig.  3) of  Olyset® nets was also higher as 
measured by I-ACT (96.4%, 95% CI 94.7–98.1%) than 
tunnel test (88.9%, 95% CI 86.2–91.7%) (OR 3.6 (3.1–4.2), 
p < 0.0001). Similar trends were seen among the deltame-
thrin nets  PermaNet® 2.0 and  NetProtect® but data are 
not shown due to the imprecision of estimates from the 
low number of nets evaluated (19 and 13, respectively).
Proportion of nets meeting the combined WHO methods
Figure  4 shows that even after 3  years of field use 
 PermaNet® 2.0 and  NetProtect® killed a greater pro-
portion of mosquitoes than  Olyset® resulting in 
a higher pass rate by WHO (combined cone/tun-
nel) methods, while there was less contract in the 
Table 5 Measurement of  12-h mortality, 24-h mortality and  blood feeding inhibition compared between WHO Tunnel 
test and I-ACT for sampled  Olyset® nets through 3 years of field use
Geometric mean (95% confidence interval) Odds ratio 95% 
confidence 
interval
p-value
Year 1 Year 2 Year 3 Overall
Olyset
 % 12 h mortality
  Tunnel test 44.2 (36.5–53.5) 55.1 (47.8–63.5) 50.3 (42.2–60.1) 49.5 (44.9–54.6) 1
  I-ACT 73.2 (68.3–78.5) 56.1 (48.65–64.7) 63.4 (57.11–70.3) 64.1 (60.1–68.3) 1.7 1.6–1.8 < 0.0001
 % 24 h mortality
  Tunnel test 61.4 (52.2–72.3) 64.7 (57.2–73.1) 67.7 (61.9–74.0) 64.4 (59.8–69.4) 1
  I-ACT 83.8 (78.9–89.1) 65.20 (59.56–71.4) 64.9 (59.15–71.2) 71.2 (67.7–74.9) 1.3 1.2–1.4 < 0.0001
 % feeding inhibition
  Tunnel test 85.3 (80.0–90.8) 91.9 (89.2–94.7) 90 (84.8–95.6) 88.9 (86.2–91.7) 1
  I-ACT 99.6 (99.3–100) 98 (95.6–99.9) 91.3 (87.2–95.8) 96.4 (94.7–98.1) 3.6 3.1–4.2 < 0.0001
Fig. 2 Mortality in susceptible Anopheles gambiae s.s. exposed to  Olyset® nets by year using the WHO tunnel bioassay (left panel) and the I-ACT 
(right panel) following WHOPES 2013 [59] and 2005 [25] guidelines for durability monitoring. Error bars indicate 95% confidence interval
Fig. 3 Mosquito blood feeding inhibition by year in susceptible An. 
gambiae s.s. exposed to  Olyset® nets using the WHO tunnel bioassay 
and I-ACT. Error bars indicate 95% confidence interval
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performance of the three products overall when tested 
using I-ACT. The data (Table 6) show that overall more 
nets passed WHO threshold criteria using I-ACT than 
using standard WHO (combined cone/tunnel) meth-
ods irrespective of brand and age (OR: 3.5, 95% CI 
1.9–6.5, p < 0.0001). The proportion of nets passing 
using combined WHO methods agreed with I-ACT for 
 NetProtect® and  PermaNet® 2.0 but differed different 
for  Olyset® with 94% passing in I-ACT vs 77% by stand-
ard bioassays (OR 5.2, 95% CI 2.3–11.8, p < 0.0001). A 
Fig. 4 Percentage of ITNs by brand and age passing bioassay criteria following WHO 2013 and 2005 guidelines as measured by standard bioassays 
(a, c) vs I-ACT (b, d) against An. gambiae s.s. (Ifakara strain) fully susceptible to all classes of insecticides
Table 6 Difference in  the  proportion of  nets passing WHO 2005 threshold criteria by  combined WHO cone and Tunnel 
test methods compared to I-ACT for sampled  Olyset®,  PermaNet® 2.0 and  NetProtect® nets
Odds ratios are calculated using pass/fail with 24 h holding times for all tests
WHOPES 2005 pass/fail criteria: tunnel test: feeding inhibition and/or ≥ 80% 24 h mortality
I-ACT: ≥ 80% 24 h mortality and/or ≥ 90% blood feeding inhibition
No. of nets 
tested
% pass WHO 2013 
criteria (n)
% pass WHO 2005 
criteria (n)
Odds ratio 95% confidence 
interval
p-value
Olyset®
 WHO methods 145 71% (n = 103) 77% (n = 111) 1
 I-ACT 145 94% (n = 134) 94% (n = 137) 5.2 2.3–11.8 < 0.0001
PermaNet® 2.0
 WHO methods 144 94% (n = 135) 94% (n = 135) 1
 I-ACT 144 98% (n = 141) 98% (n = 141) 3.1 0.8–11.8 0.092
NetProtect®
 WHO methods 143 99% (n = 141) 99% (n = 141) 1
 I-ACT 143 98% (n = 140) 97% (n = 139) 0.49 0.1–2.7 0.418
Overall
 WHO methods 432 69% (n = 379) 90% (n = 387) 1
 I-ACT 432 92% (n = 415) 97% (n = 417) 3.5 1.9–6.5 < 0.0001
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second notable difference was that holding time was 
important in determining the pass rate of  Olyset® net 
with a significant increase in the proportion of  Olyset® 
that passed when 24 h mortality vs immediate mortality 
scoring was used: 77% (95% CI 69–83%) vs 71% (95% 
CI 62–78%) pass. A small and not significant difference 
was observed in the proportion of  PermaNet® 2.0 (94% 
vs 98%) and  NetProtect® (98% vs 97%) passing by either 
WHO methods or I-ACT methods, respectively.
Non-inferiority of sampled net product
In order to measure non-inferiority of field aged nets 
 Olyset® was used as the reference net (active compara-
tor for non-inferiority testing) and the other two nets 
were compared to it. Using I-ACT data it can be seen 
that overall,  PermaNet® 2.0 and  Netprotect® killed 
greater proportion of mosquitoes than  Olyset®. Using 
a t-test of the effect difference between the products 
using the 24 h mortality endpoint with a margin of 10% 
of non-inferiority it can be seen that both  PermaNet® 
2.0 and  NetProtect® were superior to  Olyset® (Fig.  5). 
It should be noted that the figure shows a negative 
value for superior products because the effect differ-
ence is calculated by subtracting the induced mortality 
of the test net from the reference net. However, using 
the feeding inhibition endpoint, both  PermaNet® 2.0 
and  NetProtect® were non-inferior to Olyset using a 
10% margin of non-inferiority. It can, therefore, be con-
cluded that the three products are equivalent based on 
a combined mortality and feeding inhibition endpoints, 
as is current WHO practice.
Discussion
This is the first ITN durability study to compare bioeffi-
cacy of ITNs using standard WHO bioassays (cone and 
tunnel tests) with data collected from whole nets tested 
using the I-ACT. A large numbers of three brands of 
nets returned from the field were evaluated in I-ACT 
to measure their protection to users sleeping under-
neath them in the presence of natural wear and tear. 
The I-ACT allowed high throughput (48 nets per brand 
per year) to give precise estimates of overall product 
efficacy. Data from the I-ACT for the deltamethrin 
nets  PermaNet® 2.0 and  Netprotect® that function 
through rapid knock down and mortality largely agrees 
with the standard WHO methods (cone/tunnel tests). 
However, for  Olyset® that functions through the pre-
vention of feeding a greater proportion of nets passed 
using I-ACT than standard WHO methods (cone/tun-
nel tests).
It was observed that each of the three net brands 
showed lower efficacy measured by standard WHO bio-
assays compared to efficacy measured by I-ACT. This 
could be due to: (1) duration of exposure (3 min vs 12 h), 
(2) surface area of treated fabric presented to the mosqui-
toes (both standard WHO methods use 20 cm2 samples 
versus a whole net in the I-ACT) and (3) number of tarsal 
contacts with the ITN resulting in exposure to different 
dose of insecticide due to the presence of a human host 
under the net for the I-ACT. In cone test experiments, 
mosquitoes are exposed to tested ITN for only 3  min 
which may not allow the tested mosquitoes to exercise 
natural host-seeking behaviour with multiple contacts 
over the net surface resulting in a higher cumulative 
dose of insecticide. This has also been measured by other 
authors in studies to understand behavioural and physi-
ological changes in mosquitoes in relation to responses 
to insecticides. A series of studies by Angarita-Jaimes 
and colleagues using a novel video-tracking system to 
quantify the behaviour of nocturnal mosquitoes attack-
ing human hosts in the laboratory and in field observed 
that, both An. gambiae s.s. and Culex quinquefasciatus 
showed multiple contacts with bed nets when a human 
host was present [30], and this host seeking activity is 
lower for treated nets than in untreated nets [31, 32]. 
However, the I-ACT study demonstrated that these con-
tacts were sufficient to kill or inhibit feeding among the 
majority of pyrethroid susceptible mosquitoes used in 
this study.
In addition, the findings add to existing data that 
shows that the cone test underestimates the bioefficacy 
of  Olyset® that contains Permethrin, a contact irritant 
pyrethroid [15, 17, 33, 34]. During cone tests, permethrin 
causes mosquitoes to minimize contact with the netting 
fibres and they may sometimes rest on the sides of the 
Fig. 5 Non-inferiority of PermaNet 2.0 net and NetProtect combined 
24 h mortality and feeding inhibition for 3 years of data with  Olyset® 
as the reference performed in the I-ACT using a 10% margin of 
non-inferiority
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cone or cotton plug on the cone and avoid the insecticide 
and demonstrate frequent take offs from the net [28].
The tunnel test was developed as a consequence of 
the need to measure feeding inhibition of permethrin-
treated nets [35] and has also shown some use in evalu-
ating products that fail cone tests including chlorfenapyr 
products as it allows mosquitoes to exhibit flight and host 
seeking feeding behaviour in a natural simulated condi-
tion [36]. However, as with cone test, the tunnel test has 
some limitations. The overall pass rate (using 12 or 24-h 
mortality and blood feeding inhibition), as measured 
following both WHO 2005 and 2013 criteria, was lower 
compared to that measured by I-ACT. A possible expla-
nation for this observation is that, the baits used in tun-
nel tests are rabbits that are not the preferred bait for An. 
gambiae s.s. that feeds almost exclusively on humans [22, 
37]. Therefore, during standard tunnel test experiments, 
mosquitoes may be less responsive to non-preferred bait 
and remain in the releasing chamber throughout the 
exposure time without interacting with the ITN sam-
ple resulting in a lower cumulative exposure to insecti-
cide. Additionally, using a whole net in the I-ACT killed 
more mosquitoes possibly due to the large surface area of 
insecticide available for mosquitoes to interact with. It is 
known from repellent testing that use of a non-preferred 
bait will overestimate repellent efficacy [38]. However, 
a similar number of  PermaNet® 2.0 and  NetProtect® 
passed the combined WHO tests and the I-ACT whereas 
fewer  Olyset® passed combined WHO tests indicat-
ing that the WHO tests are conservative and therefore 
unlikely to pass a product that is of low efficacy. As the 
I-ACT is a less conservative test it may have use for early 
screening of new insecticide treated nets including those 
with irritant insecticides or those that function through a 
mode of action other than rapid knockdown before more 
costly experimental hut tests.
The overall percentage of  Olyset® nets that passed tun-
nel test following WHO 2013 guidelines was marginally 
lower than when following WHO 2005 guidelines [25]. 
This suggests that reinstating the WHO 2005 pass/fail 
efficacy criteria may be justified to avoid missing prod-
ucts that are efficacious during early testing. This will also 
align tunnel test holding times with those of cone bioas-
says and experimental huts (24  h). It may also be justi-
fiable when testing some products to hold mosquitoes 
for even longer than 24 h as some authors have done to 
measure the effects of slow acting insecticides [39, 40]. 
This simple pairwise test between the two guidelines 
demonstrated the usefulness of exploring the impact of 
holding time on the outcome of product tests.
The mode of action of insecticides used on ITNs is an 
important consideration when selecting bioassays. New 
products with modes of action different from pyrethroids 
(which are fast acting and neurotoxic) are coming to mar-
ket and there is a need for a suitable means to bioassay 
them. An example is chlorfenapyr, which acts by disrupt-
ing metabolic respiratory pathways (oxidative phospho-
rylation) in the cells of mitochondria and that require the 
conversion of the active compound through metabolism 
[41]. The conversion is optimal at night and is maximized 
when mosquitoes are metabolically active i.e. during the 
active part of their circadian rhythm and flying during 
host seeking [42]. Cone tests are usually conducted dur-
ing the day and take 3  min exposure time with no bait 
involved. Findings from two well conducted studies by 
Oxborough et  al. and Ngufor et  al. observed extremely 
low levels of mortality caused by chlorfenapyr compared 
to pyrethroids when assessed by cone test, but excellent 
effect against resistant mosquitoes when tested in experi-
mental huts [39, 43]. These data again suggest that cone 
test may be best suited for fast acting non-irritant insecti-
cides [35] and there is a need to be open to exploring new 
bioassays for new mode-of-action products. The higher 
pass rate of I-ACT compared to standard WHO tests 
may be useful when conducting “quick and dirty” tests 
for new products to avoid early “kill” of promising prod-
ucts because they are failing to pass bioefficacy criteria 
in phase I laboratory tests when they may prove highly 
efficacious in gold standard experimental hut tests (Phase 
II).
Ifakara Ambient Chamber Test may be useful in evalu-
ating new products that function through either mortal-
ity or feeding inhibition. Tests are conducted at times 
when mosquitoes are metabolically active, and using 
the preferred host of Afro-tropical malaria vectors. The 
advantage of using the I-ACT is that nets are evaluated 
using mortality and feeding inhibition using just one 
test rather than having to perform the cone (for mor-
tality) followed by the tunnel test bioassays (for feeding 
inhibition or mortality at night). Regarding the issue of 
precision in outcome measure estimates, the durability 
study performed here in the I-ACT used 30 mosquitoes 
per chamber per night of experiment and allowed large 
numbers of nets to be evaluated without exhausting the 
insectary which is always a concern when product test-
ing. It is important to assess a large number of nets in 
durability studies to allow a sufficient sample of nets to be 
returned from the field to capture the large heterogeneity 
in product performance i.e. fabric integrity and insecti-
cidal content, and using a random sampling framework 
that is large enough to avoid sampling bias such as the 
Hawthorne effect [44].
When the efficacy of ITNs was compared using 
standard WHO assays and I-ACT, it was seen that most 
of the tested nets were extremely effective against mos-
quitoes and passed WHO criteria of feeding inhibition 
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and/or mortality using the pyrethroid susceptible An. 
gambiae s.s. (Ifakara) strain even after 3  years of use 
with natural damage and insecticide depletion from 
the field. This has also been shown by other research 
in Tanzania [34, 45, 46]. Many of the tested nets were 
damaged. The median hole surface area was 459 cm2 in 
Olyset, 295  cm2 in Permanet and 152  cm2 in NetPro-
tect in year 3, which means that most surviving nets 
were in the “damaged” category, but remained highly 
protective.
In addition, a simple non-inferiority test was con-
ducted using WHO criteria to evaluate the effect of dif-
ference between products for mortality and feeding 
inhibition.  Olyset® was used as the reference product 
(first in class or active comparator) against which the two 
other brands (second in class, test product or innovator 
product) were compared since it is the standard of care 
in Tanzania.  PermaNet® 2.0 and  Netprotect® were non-
inferior compared to  Olyset® on the feeding inhibition 
endpoint and superior to  Olyset® on the 24-h mortality 
endpoint when measured in the I-ACT. The WHO passes 
a product based on a combination of mortality and feed-
ing inhibition, and based on these criteria,  PermaNet® 
2.0 and  Netprotect® were non-inferior to  Olyset® based 
on data for three-year durability. This was also seen with 
WHO bioassays:  Olyset® demonstrated lower mortal-
ity and similar feeding inhibition to  PermaNet® 2.0 and 
 Netprotect® when tested using cone tests and tunnel 
tests. Estimates of efficacy from the sample of 144 nets 
per brand were very precise and a 10% effect difference in 
mortality could be observed. However, it is unlikely that 
144 nets per brand could be cost effectively evaluated in 
experimental huts. A comparison study between Ifakara 
experimental huts and the I-ACT using 24-h mortal-
ity and feeding inhibition outcome measures is in pro-
gress (Moore et  al., pers. commun.) and will show how 
I-ACT and gold standard experimental huts compare 
for non-inferiority evaluation of ITNs. This is important 
since experimental huts are used to measure entomologi-
cal correlates of the epidemiological effectiveness i.e. the 
public health benefit of interventions [47].
Therefore, the I-ACT could prove useful for testing 
insecticidal materials that can provide a high through-
put option for evaluating functional bioefficacy of ITNs 
i.e. the true protection as a function of damage and bio-
availability of insecticide in durability studies. Functional 
bioefficacy i.e. incorporating insecticidal effectiveness 
has also been suggested by WHO’s Malaria Policy Advi-
sory committee to be included for net durability assess-
ment [48]. While the methods presented here may not be 
useful for operational durability monitoring they may be 
useful for consideration in WHO “Phase 3” community 
field assessments of ITNs.
In this new assay, recapture of released mosquitoes is 
99% so 30 mosquitoes were consistently “captured” every 
night I every chamber which is unlikely to be the case in 
standard experimental hut studies [45, 49–57]. Experi-
mental hut studies rely on wild mosquitoes entering the 
hut, and the nightly number of mosquitoes captured is 
highly variable and consequently substantial replication 
is required to obtain adequate precision to estimate true 
effect differences between products [23]. As mosquito 
densities fluctuate due to seasonality in rainfall it is useful 
to have a whole net assay that is not dependent on field 
populations of mosquitoes that may limit the windows 
of opportunity to conduct tests with adequate mosquito 
densities to achieve power. Whole net bioassays where 
the interaction between insecticide and fabric integrity is 
measured are important for selecting between products 
or ranking their durability [48]. Bioassays that assess only 
the insecticidal bioefficacy of a net sample may favour 
poor quality nets that tear easily reducing user protection 
and consequently user acceptance, which will eventually 
lead to the user discarding the net [58].
The experimental hut bioassay that simulates domes-
tic conditions and allows nets to be tested against wild 
mosquitoes is the definitive test of ITN efficacy [43]. 
This study had several limitations. Firstly, I-ACT uses 
laboratory-reared mosquitoes, which means it relies 
on laboratory strains that may have different resistance 
mechanisms to those locally or limited genetic diver-
sity. Secondly, the I-ACT test is a more expensive infra-
structure to establish compared to small WHO cones 
and WHO tunnel glass chambers, requires space and it 
is immovable. The assay must be conducted in climate-
controlled chambers or in areas with suitable ambient 
conditions to conduct the tests. In contrast standard 
WHO cones and tunnel chambers which can be taken 
anywhere and tests conducted provided the environment 
is set to standard conditions for conducting tests. The 
I-ACT needs to be compared to experimental hut tests, 
but it did agree well with findings of standard WHO 
methods using pyrethroid susceptible mosquitoes. Evalu-
ations of ITNs with pyrethroid resistant strains as well 
as using dual active ITNs will be reported in subsequent 
publications.
Based on the data here presented, the overnight I-ACT 
may be a bridge between the lab and the field. Data agree-
ment with standard WHO testing methods was excellent, 
with high sensitivity and specificity. It allows mosqui-
toes to host seek during the active phase of the circadian 
rhythm, and have multiple contacts with treated net-
ting in a more realistic way. It uses the preferred human 
host but allows laboratory-reared mosquitoes to be used. 
This improves safety for human volunteers because lab-
oratory-reared mosquitoes are disease free and allows 
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sufficient numbers of mosquitoes to be released to reach 
the power needed to conduct precise comparisons of 
product performance.
Conclusion
Findings from this study showed that, I-ACT can be 
used for high throughput evaluation of whole nets from 
ITN durability studies. The new assay may provide use-
ful additional information and could act as a link between 
lab tests and field experiments measuring composite bio-
efficacy and net physical integrity with both mortality 
and feeding inhibition endpoints. For the three products 
evaluated in this study the bioassay agreed with stand-
ard WHO tests for deltamethrin products and measured 
higher pass for the permethrin-treated nets than stand-
ard WHO tests. I-ACT allows mosquitoes to interact 
with a preferred host sleeping under a net as it would be 
encountered in the field using a standard number of mos-
quitoes released to improve the precision of efficacy esti-
mates and safety of human participants.
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